BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  Ono Pharmaceutical Company, Ltd. Selects Medidata To Power Clinical Trials Exploring Additional Cancer Indications For Immunotherapy Drug OPDIVO (Nivolumab)

  January 27, 2016

   · 

  1 min read
• BioForest

  FDA Approves Aortica To Supply Aortafit System For Starnes’ Physician-Sponsored IDE Study

  January 27, 2016

   · 

  4 min read
• Drug Development

  Cardiome Pharma Corp. Announces Filing Of Orphan Drug Application For Oral Vernakalant With U.S. FDA

  January 27, 2016

   · 

  5 min read
• FDA

  Vertex Release: Health Canada Approves PrORKAMBI (Lumacaftor/Ivacaftor) - The First Medicine To Treat The Underlying Cause Of Cystic Fibrosis For People Ages 12 And Older With Two Copies Of The F508del Mutation

  January 27, 2016

   · 

  9 min read
• BioMidwest

  AMD LASERS Announces Free Global Dental Laser Certification Program

  January 27, 2016

   · 

  2 min read
• Drug Development

  Ipsen Announces Publication In Pediatrics Of The Results Of The Phase III Randomized Study Showing The Efficacy And Safety Of Dysport(Abobotulinumtoxina) In Children With Dynamic Equinus Foot Deformity Due To Cerebral Palsy

  January 27, 2016

   · 

  11 min read
• Biotech Beach

  Batu Biologics Issues Shareholder Update On Upcoming Milestones For 2016

  January 27, 2016

   · 

  1 min read
• Biotech Bay

  EBD Group Release: Biotech Showcase 2016 Reports Record High Attendance This Year

  January 27, 2016

   · 

  4 min read
• FDA

  FDA Approves Takeda’s Dexilant SoluTab (dexlansoprazole)

  January 27, 2016

   · 

  9 min read
• Business

  ImmunoCellular Therapeutics, Ltd Enters Into A Sponsored Research Agreement With The University of Maryland, Baltimore To Pursue Multiple Enhancements Of Its Cancer Immunotherapy Platforms

  January 27, 2016

   · 

  4 min read